Registration of Idarucizumab for Patients with IntraCranial Hemorrhage

NCT04062097 · clinicaltrials.gov ↗

COMPLETED

Status

104

Enrollment

OTHER

Sponsor class

Conditions

Intracranial Hemorrhage

Interventions

DRUG: Dabigatran Etexilate Oral Capsule [Pradaxa]
DRUG: Idarucizumab 2.5 GM/50 ML Intravenous Solution [PRAXBIND]
DRUG: Vitamin K antagonist

Sponsor

University Hospital, Essen